Glaxo review could see it sell Ribena and Lucozade
GlaxoSmithKline could sell Lucozade and Ribena after Britain’s biggest pharmaceuticals firm today set out plans for a “strategic review” of the drinks brands.
The drugmaker’s chief executive, Sir Andrew Witty, said he was focused on the “two places where there are cast-iron synergies between pharma and the consumer business, which are over-the-counter medicines, such as Panadol, and emerging markets.
Lucozade and Ribena are iconic brands, but don’t naturally fit into those two places.
Witty said its review, which will be complete by the middle of this year, involved “truly no decisions taken or options ruled out — we could increase investments in certain parts of the world, find a partner, or divest the products.”
The announcement came as GSK suffered from European governments cutting back on healthcare and drugs spending, with annual turnover falling 1% to £26.4 billion in 2012, and pre-tax profits slipping 4% to £7.6 billion.
Total sales in emerging markets now account for just over a quarter of GSK’s business.
- 1 The truth about 'girl things': Three cheers for Heather Watson's honesty
- 2 Man who held up 'hire me' sign at Waterloo station returns a year later with 'I'm hiring' sign
- 5 Men behaving badly: Urinating while standing, 'manspreading' and the gendering of selfishness
Nigel Farage: NHS might have to be replaced by private health insurance
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
French court convicts three over homophobic tweets, in case hailed as a 'significant victory' by LGBT rights campaigners
British Muslim school children suffering a backlash of abuse following Paris attacks
George Galloway condemns 'racist, Islamophobic, hypocritical rag' Charlie Hebdo at freedom of speech rally
Islamic history is full of free thinkers - but recent attempts to suppress critical thought are verging on the absurd
iJobs Money & Business
Negotiable: Recruitment Genius: A Tax Assistant is required to join a leading ...
£16000 - £25000 per annum: Recruitment Genius: This is an exciting opportunity...
£45000 - £47000 per annum + bonus + benefits: Ashdown Group: Java Developer / ...
£35000 - £38000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...